Pathways Case Studies: October 2023 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for October include the following sub-specialties Breast Pathology, Gynecological...
MCL Rare Coagulation Disorder Patient Information MC1235264
MCL Rare Coagulation Disorder Patient Information Complete print Reset Form Rare Coagulation Disorder Patient Information Instructions Genetic testing rare hereditary disorders blood coagulation
December 2023 - Gastroenterology Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Gastroenterology Pathology.
December 2023 - Coagulation and Hematopathology - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case’s sub-specialties are Coagulation and Hematopathology.
Mayo Clinic Laboratory and Pathology Research Roundup: March 20 - Insights
This week’s Research Roundup highlights how AKT-phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1-MAPK interaction.
April 2022 - Breast Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Breast Pathology.
February 2023 - Endocrine Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Endocrine Pathology.
People Archives - Page 33 of 35 - Insights
Skip to Content MayoACCESS MayoLINK...
Gadolinium-based contrast agents (GBCAs) have revolutionized MRIs by increasing the clinical utility and detection sensitivity of these exams. GBCAs also contain gadolinium, a rare earth metal with unique chemical properties. This article...
Mayo Clinic Laboratories’ novel lupus testing, offered in partnership with Progentec Diagnostics, can help characterize disease activity and predict disease flares.